About: Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) مقالة علمية تنشرت ف 1 أكتوبر 2001 (ary) наукова стаття, опублікована в жовтні 2001 (uk) im Oktober 2001 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en octobre 2001 (fr) artículu científicu espublizáu n'ochobre de 2001 (ast) scientific article published on 01 October 2001 (en)
publication date	wds:Q74541105-A63B9942-F0BC-4574-A276-76819F2158C6
publication date	2001-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74541105-F2B610C0-4292-44D2-9D43-D10C7DA18E69
language of work or name	English
cites work	wds:Q74541105-0BBADB61-13FE-4E5D-B524-6431C7172D69 wds:Q74541105-1B5D2DDF-C683-4928-AC5F-DB067B0A9125 wds:Q74541105-2AEB7AE9-513E-4B43-B1FE-4F624E0A99C6 wds:Q74541105-2C186B9E-35F5-4579-95EF-AABDD7C1915D wds:Q74541105-34813497-E3E9-4896-83CE-6BD6D34E13FC wds:Q74541105-397ADCA2-E3F6-4F03-AB45-15E8B4CD42AF wds:Q74541105-403F90B4-C2D3-4A66-BE14-657F4D219A5B wds:Q74541105-425513BC-3F06-4927-A6B6-D23A4C9DAC25 wds:Q74541105-4D23551C-4B77-4006-B876-CE5EAEE81862 wds:Q74541105-5062897A-89D8-4ABA-8C16-7FC21F372336 wds:Q74541105-5630F0C6-6788-447F-8BE5-DE7B88F76391 wds:Q74541105-58E2F039-9D71-4EA9-A219-58A21F97BE42 wds:Q74541105-5A6DE643-F34E-473A-B00D-4F87C5D0073A wds:Q74541105-5A878DA0-AB7A-408B-BA3F-78365696F5A8 wds:Q74541105-5BCA6576-91B5-404B-B200-7D9A6B880788 wds:Q74541105-62F4F31B-4072-48C1-81D7-CD39F3034140 wds:Q74541105-65EDB8E0-A2C7-454A-8512-208AD16C3A9D wds:Q74541105-6D2A9ECB-D7E1-4DA9-82D8-4CCEBB0529FC wds:Q74541105-72D6DE14-570B-4C64-B212-1B059F3AE0B2 wds:Q74541105-7C3ADD42-A0AA-4993-A7AE-80FCC63CA8B7 wds:Q74541105-839FB848-50B7-434F-9BF4-77F66B542AA0 wds:Q74541105-83B2F1D3-5F0D-497C-900C-BF0F14D7F215 wds:Q74541105-982CA51B-989A-4C84-A4B9-B5CB447A8E4E wds:Q74541105-99451B0C-7560-4333-B186-883E73F0DE6C wds:Q74541105-9D743605-D46D-41E1-92A1-8D14683FDD0D wds:Q74541105-A0BF6542-2C50-4E7E-B93E-F5D937436D2F wds:Q74541105-A3CA6AE6-C935-4A92-A512-4418C874AF40 wds:Q74541105-AE52CF7D-0450-4FFC-A037-88C3E544A643 wds:Q74541105-B2C47FAB-35C1-4E43-B990-855034B3D2F4 wds:Q74541105-B9C79C33-D7EA-41B4-90B7-D773296E4553 wds:Q74541105-B9FF149E-AF19-41D6-AD0A-4319A7909928 wds:Q74541105-BE5F89C8-3CBA-4037-A275-116269D57639 wds:Q74541105-C52FE494-36FC-482D-8143-6BF9687EE915 wds:Q74541105-D6BB016D-684A-4CF7-9A9A-77904E65E21A wds:Q74541105-DF4F8C28-3A03-4796-9460-051ED9C312A5 wds:Q74541105-E08AAD0F-F1E5-4110-9067-563EA0F53848 wds:Q74541105-E5082E0A-B285-4431-A217-0EA17C2D8655
cites work	Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group Efficacy of a pneumococcal conjugate vaccine against acute otitis media Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children Carriage of pneumococci after pneumococcal vaccination Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid Pneumococcal conjugate vaccines Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine Conjugate vaccines and the carriage of Haemophilus influenzae type b. Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. Mucosal immune response in the ear, nose and throat Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada Involvement of phospholipid end groups of group C Neisseria meningitidis and Haemophilus influenzae type b polysaccharides in association with isolated outer membranes and in immunoassays Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers The pneumococcal protein conjugate vaccines Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model
author name string	wds:Q74541105-46564D06-0860-4E04-B965-966830D81638 wds:Q74541105-5EE029B3-5A75-4D12-BB41-A1358C553B84 wds:Q74541105-80E88CF6-9A59-452C-9FC3-CEC731AE8DE9 wds:Q74541105-93DC4D80-ABA5-4ED3-9B33-244AC09A062D
author name string	J Eskola A Nurkka H Ahman M Yaich
rdfs:label	Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT (en) Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT (nl)
skos:prefLabel	Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT (en) Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT (nl)
name	Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT (en) Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software